Blood serotonin in schizophrenic children. A preliminary study

Area of Science:

• Neuroscience
• Child Psychiatry
• Biochemistry

Background:

• Schizophrenia is a severe mental disorder with early onset in some children.
• Serotonin, a neurotransmitter, plays a role in various brain functions and has been implicated in psychiatric disorders.

Purpose of the Study:

• To investigate blood serotonin levels in children diagnosed with schizophrenia.
• To explore the relationship between serotonin levels and clinical symptoms or cognitive function in pediatric schizophrenia.

Main Methods:

• Blood samples were collected from children diagnosed with schizophrenia (early onset) and age-matched controls.
• Serotonin concentrations in blood were quantified using biochemical assays.
• Patients were assessed for symptom severity (florid psychosis vs. remission) and intelligence quotient (IQ).

Main Results:

• Mean blood serotonin levels were numerically higher in schizophrenic children than in controls, but this difference was not statistically significant.
• Significantly elevated blood serotonin levels were observed in patients experiencing florid psychosis compared to those in remission.
• Higher serotonin levels correlated with lower IQ scores in the pediatric schizophrenia group.

Conclusions:

• Blood serotonin levels may be altered in early-onset childhood schizophrenia.
• Elevated serotonin is associated with more severe psychotic symptoms and cognitive impairment in this population.
• Further research is warranted to understand the role of serotonin in the pathophysiology of pediatric schizophrenia.